| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
51,727 |
43,022 |
$2.74M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
9,477 |
8,749 |
$733K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,607 |
6,540 |
$557K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
16,210 |
14,236 |
$486K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,747 |
4,208 |
$383K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
2,303 |
2,058 |
$131K |
| 99460 |
|
1,588 |
1,438 |
$125K |
| 90670 |
|
7,460 |
6,850 |
$122K |
| 90461 |
|
12,075 |
10,926 |
$106K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
1,080 |
692 |
$104K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,081 |
1,883 |
$68K |
| 99462 |
|
1,891 |
1,517 |
$65K |
| 87428 |
|
2,210 |
1,795 |
$49K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,339 |
1,978 |
$49K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,848 |
1,377 |
$48K |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
3,114 |
2,733 |
$48K |
| 90716 |
|
1,434 |
1,239 |
$34K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,672 |
2,264 |
$28K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
507 |
415 |
$25K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,078 |
3,482 |
$23K |
| 90707 |
|
1,427 |
1,229 |
$20K |
| 83655 |
|
1,978 |
1,638 |
$16K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,269 |
1,130 |
$14K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
178 |
158 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
812 |
561 |
$6K |
| 90677 |
|
512 |
406 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
48 |
47 |
$4K |
| 87081 |
|
549 |
488 |
$3K |
| 87807 |
|
418 |
323 |
$3K |
| 90651 |
|
48 |
41 |
$3K |
| 90686 |
|
1,267 |
1,015 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
12 |
$2K |
| 92551 |
|
173 |
152 |
$2K |
| 99442 |
|
74 |
30 |
$1K |
| 90698 |
|
5,742 |
5,329 |
$1K |
| 99173 |
|
243 |
203 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
73 |
70 |
$1K |
| 99381 |
|
15 |
13 |
$611.82 |
| 90715 |
|
94 |
79 |
$590.89 |
| 96127 |
|
108 |
97 |
$264.86 |
| 81002 |
|
91 |
77 |
$208.99 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
34 |
26 |
$208.59 |
| 90633 |
|
902 |
795 |
$160.00 |
| 96160 |
|
68 |
47 |
$45.62 |
| 90744 |
|
3,587 |
3,368 |
$27.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
127 |
76 |
$1.85 |
| 90656 |
|
14 |
14 |
$0.30 |
| 90680 |
|
5,340 |
4,977 |
$0.13 |
| 90696 |
|
340 |
274 |
$0.00 |
| 99000 |
|
168 |
153 |
$0.00 |
| 36416 |
|
974 |
742 |
$0.00 |
| 90697 |
|
1,067 |
874 |
$0.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
83 |
51 |
$0.00 |
| 90710 |
|
109 |
75 |
$0.00 |